MedTrace Logo

Senofilcon A Investigational Manufacturing Process

NCT01951703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

To evaluate the impact of a new contact lens hydration process

Conditions

  • Visual Acuity
  • Comfort
  • Overall Vision

Interventions

DEVICE

senofilcon A

Control, senfilcon A

DEVICE

senofilcon A

Test, senofilcon A

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Brian Pall, OD · Johnson & Johnson Vision Care

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01951703 on ClinicalTrials.gov